GLIMEPIRIDE clinical trials

A Multicentre, Randomized, Double-blind, Placebo-controlled, phase III study to evaluate the efficacy and safety of Pioglitazone co-administration in patients with type II diabetes with insufficient glycemic control with Metformin and Empagliflozin combination therapy

This study is looking at a new way to treat Type 2 diabetes. It aims to see if adding an extra medication, Pioglitazone, to a common treatment (Metformin and Empagliflozin) helps people manage their blood sugar better. It also checks if this new combination is safe.